policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
AVMA presents Excellence Awards
During AVMA Convention 2018 this July in Denver, a number of individuals received AVMA Excellence Awards for contributions in areas such as the…
JAVMA news
Extralabel drug substitution runs afoul of law
Extralabel use of drugs can give veterinarians effective options in treating patients, but there are limitations veterinarians should be aware of when…
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
JAVMA news
Drug's sale halted over arsenic concerns
A pharmaceutical company planned to halt sales of a drug used to treat a parasitic disease and increase growth in chickens after it was found that use…
JAVMA news
Groups provide new guidance on antimicrobials
The AVMA, Canadian VMA, and Federation of Veterinarians of Europe are calling for continuous monitoring of antimicrobial use and resistance at a…